Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Fran Schulz currently holds 15,100 shares of Senti Biosciences, Inc. (SNTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Fran Schulz has been a net buyer of SNTI stock. They have purchased $47.5K and sold $0 worth of shares.
Fran Schulz's most recent insider trade was on Aug 14, 2026, when they purchased 10,000 shares at $4.75 per share.
Fran Schulz serves as Executive at Senti Biosciences, Inc. (SNTI). They have executed 2 insider transactions totaling $47.5K over their tenure at the company.
Fran Schulz holds the position of Executive at Senti Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Fran Schulz has shown a buying trading pattern, with $47.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Fran Schulz was on Aug 14, 2026, when they purchased $47.5K worth of FOCL shares. This transaction involved 10,000 shares at $4.75 per share.
Fran Schulz currently owns 15,100 shares of Senti Biosciences, Inc. (SNTI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Fran Schulz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Fran Schulz has 2 Form 4 filings on record as an insider at Senti Biosciences, Inc..
Set alerts for Fran Schulz and 40,000+ other insiders.